TP53 and cancer: Blagosklonny M. et al., demonstrated that the treatment of several cancer cell lines with BA resulted in the destabilization of mutated p53 with no influence on wild-type p53 forms, thus, leading to the restoration of the activity of the wild-type p53 in p53 heterozygous tumor cells [117].